Although extensive studies have revealed that the activation of oncogene KRAS and the inactivation of some tumor suppressor genes, such as APC, TP53, and 18q LOH, are involved in the pathological process of CRC [6–9], the bioenergetic alterations associated with this process are still obscure [10]. This evidence concerns the gene KRAS and colorectal carcinoma.